Close Menu

Henry M. Jackson Foundation for the Advancement of Military Medicine

In PNAS this week: genetic diversity of SARS-CoV-2 indicates neutral evolution, portable RT-LAMP method to detect SARS-CoV-2, and more.

The partners signed a CRADA to develop biomarkers discovered by the Center for Prostate Disease Research for use in clinical diagnostic testing. 

PrimeraDx, a Mansfield, Mass.-based molecular diagnostics firm, is on track to submit its highly multiplexed PCR-based testing system and associated assay for Clostridium difficile to the US Food and Drug Administration this quarter, CEO Matt McManus said recently.

NEW YORK (GenomeWeb News) – The Rutgers Cell and DNA Repository, or RUCDR, has landed a $2.4 million grant from the Henry M. Jackson Foundation for the Advancement of Military Medicine to study mental health risk among service men and women.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.